Sujal V. Deshmukh - Concepedia

Author

Sujal V. Deshmukh

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

Deshmukh, Sujal, Deshmukh, Sujal V., Sujal Deshmukh, Sujal V Deshmukh, Sujal V. Deshmukh

Publications

972

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)The University of Texas Medical Branch at Galveston Novartis (United States)University of Missouri–Kansas City United States Military Academy

About

Sujal V. Deshmukh is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	547
2	Biochemistry	7	7	203
3	Natural Sciences	4	4	159
4	Health Sciences	1	1	17
5	Biostatistics	1	1	17

Sujal V. Deshmukh

Publications

940

Citations

H-Index

Page 1

	Year	Citations
Transplacental Transfer and Metabolism of Buprenorphine Tatiana Nanovskaya, Sujal V. Deshmukh, Monica Brooks, Journal of Pharmacology and Experimental Therapeutics	2002	159
Bidirectional transfer of methadone across human placenta Ilona Nekhayeva, Tatiana Nanovskaya, Sujal V. Deshmukh, Biochemical Pharmacology Substance AbuseHuman PlacentaGynecologyMaternal HealthPharmacotherapy	2004	85
MK-2461, a Novel Multitargeted Kinase Inhibitor, Preferentially Inhibits the Activated c-Met Receptor Bo‐Sheng Pan, Grace K.Y. Chan, Mélissa Chénard, Cancer Research Activated C-met ReceptorCell CultureCancer BiologyTumor BiologyMolecular Pharmacology	2010	82
Methadone metabolism by human placenta Tatiana Nanovskaya, Sujal V. Deshmukh, Ilona Nekhayeva, Biochemical Pharmacology Human PlacentaMedicineMaternal HealthMaternal-fetal MedicineMetabolomics	2004	69
Genetic and Pharmacological Inhibition of PDK1 in Cancer Cells Kumiko Nagashima, Stuart D. Shumway, Sriram Sathyanarayanan, Journal of Biological Chemistry	2010	64
Discovery of a 5<i>H</i>-Benzo[4,5]cyclohepta[1,2-<i>b</i>]pyridin-5-one (MK-2461) Inhibitor of c-Met Kinase for the Treatment of Cancer Jason D. Katz, James P. Jewell, David Guérin, Journal of Medicinal Chemistry Tumor BiologyAberrant C-met SignalingDrug TargetC-met KinaseBiochemistry	2011	60
Aromatase Is the Major Enzyme Metabolizing Buprenorphine in Human Placenta Sujal V. Deshmukh, Tatiana Nanovskaya, Mahmoud Ahmed Journal of Pharmacology and Experimental Therapeutics	2003	51
The discovery of 6-amino nicotinamides as potent and selective histone deacetylase inhibitors Christopher L. Hamblett, Joey L. Methot, Dawn M. Mampreian, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineNatural SciencesRational Drug Design	2007	43
Design of novel histone deacetylase inhibitors Phieng Siliphaivanh, Paul E. Harrington, David J. Witter, Bioorganic & Medicinal Chemistry Letters Histone ModificationsChromatinMedicinal ChemistryChromatin RemodelingMedicine	2007	42
Discovery of 1-[3-(1-Methyl-1<i>H</i>-pyrazol-4-yl)-5-oxo-5<i>H</i>-benzo[4,5]cyclohepta[1,2-<i>b</i>]pyridin-7-yl]-<i>N</i>-(pyridin-2-ylmethyl)methanesulfonamide (MK-8033): A Specific c-Met/Ron Dual Kinase Inhibitor with Preferential Affinity for the Activated State of c-Met Alan B. Northrup, Matthew H. Katcher, Michael D. Altman, Journal of Medicinal Chemistry Drug TargetActivated StateChemical BiologyPharmaceutical ChemistryTumor Biology	2013	32

Page 1